Related references
Note: Only part of the references are listed.Risk of Mortality Associated with Non-selective Antimuscarinic medications in Older Adults with Dementia: a Retrospective Study
Nandita Kachru et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2020)
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study
Carol A. C. Coupland et al.
JAMA INTERNAL MEDICINE (2019)
Anticholinergic Drug Burden Tools/Scales and Adverse Outcomes in Different Clinical Settings: A Systematic Review of Reviews
Tomas J. Welsh et al.
DRUGS & AGING (2018)
Risk of Mortality Associated with Anticholinergic Use in Elderly Nursing Home Residents with Depression
Satabdi Chatterjee et al.
DRUGS & AGING (2017)
Antimuscarinic Medication Use in Elderly Patients with Overactive Bladder
Nandita Kachru et al.
DRUGS & AGING (2016)
Anticholinergic Medication Use and Risk of Fracture in Elderly Adults with Depression
Satabdi Chatterjee et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2016)
Anticholinergic Medication Burden and 5-Year Risk of Hospitalization and Death in Nursing Home Elderly Residents With Coronary Artery Disease
Davide L. Vetrano et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2016)
Health Resource Utilization and Cost for Patients with Incontinent Overactive Bladder Treated with Anticholinergics
Alon Yehoshua et al.
Journal of Managed Care & Specialty Pharmacy (2016)
Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis
Kimberley Ruxton et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
The Association Between Anticholinergic Medication Burden and Health Related Outcomes in the 'Oldest Old': A Systematic Review of the Literature
Karen Cardwell et al.
DRUGS & AGING (2015)
Comparison of Anticholinergic Risk Scales and Associations with Adverse Health Outcomes in Older People
Mohammed Saji Salahudeen et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2015)
Use of Medications with Anticholinergic Activity and Self-Reported Injurious Falls in Older Community-Dwelling Adults
Kathryn Richardson et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2015)
American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults
Sue Radcliff et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2015)
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
Peter C. Austin et al.
STATISTICS IN MEDICINE (2015)
Impact of urinary incontinence on healthcare resource utilization, health-related quality of life and productivity in patients with overactive bladder
Derek H. Tang et al.
BJU INTERNATIONAL (2014)
Exposure to Anticholinergic and Sedative Drugs, Risk of Falls, and Mortality An Elderly Inpatient, Multicenter Cohort
Virginie Dauphinot et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2014)
Chapter 1: The Conditions of Neurogenic Detrusor Overactivity and Overactive Bladder
Francois Haab
NEUROUROLOGY AND URODYNAMICS (2014)
Associations of drug burden index with falls, general practitioner visits, and mortality in older people
Prasad S. Nishtala et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2014)
Risk of Hospitalization and Use of First-Versus Second-Generation Antipsychotics Among Nursing Home Residents
Rajender R. Aparasu et al.
PSYCHIATRIC SERVICES (2014)
Propensity Score Methods for Confounding Control in Nonexperimental Research
M. Alan Brookhart et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2013)
Risk of Falls and Fractures in Older Adults Using Atypical Antipsychotic Agents: A Propensity Score-Adjusted, Retrospective Cohort Study
Satabdi Chatterjee et al.
AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY (2012)
Antimuscarinics for the treatment of overactive bladder: understanding the role of muscarinic subtype selectivity
Karin Glavind et al.
INTERNATIONAL UROGYNECOLOGY JOURNAL (2011)
Risk of Serious Falls Associated With Oxybutynin and Tolterodine: A Population Based Study
Tara Gomes et al.
JOURNAL OF UROLOGY (2011)
The Influence of an Overactive Bladder on Falling: A Study of Females Aged 40 and Older in the Community
Seung-Jin Moon et al.
International Neurourology Journal (2011)
An International Urogynecological Association (IUGA)/International Continence Society (ICS) Joint Report on the Terminology for Female Pelvic Floor Dysfunction
Bernard T. Haylen et al.
NEUROUROLOGY AND URODYNAMICS (2010)
Medicinal Chemistry and Therapeutic Potential of Muscarinic M3 Antagonists
Ilaria Peretto et al.
MEDICINAL RESEARCH REVIEWS (2009)
Burden of Illness Associated With Lower Urinary Tract Symptoms Including Overactive Bladder/Urinary Incontinence
Hema Kannan et al.
UROLOGY (2009)
Hospitalization Risk Associated with Typical and Atypical Antipsychotic Use in Community-Dwelling Elderly Patients
Rajender R. Aparasu et al.
AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY (2008)
The anticholinergic risk scale and anticholinergic adverse effects in older persons
James L. Rudolph et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Muscarinic receptor antagonists for overactive bladder
Paul Abrams et al.
BJU INTERNATIONAL (2007)
Anticholinergic medications - Use among older adults with memory problems
Rachel F. Kemper et al.
JOURNAL OF GERONTOLOGICAL NURSING (2007)
Retrospective evaluation of outcomes in patients with overactive bladder receiving tolterodine versus oxybutynin
Zhanna Jumadilova et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2006)
The anticholinergic drug scale as a measure of drug-related anticholinergic burden: Associations with serum anticholinergic activity
Ryan M. Carnahan et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Anticholinergics for overactive bladder. Does subtype selectivity play a role?
M. C. Michel et al.
UROLOGE (2006)
Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder
Paul Abrams et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Pharmacotherapy for overactive bladder - An evidence-based approach to selecting an antimuscarinic agent
Rodney A. Appell
DRUGS (2006)
Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients
GG Kay et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)
The effects of antimuscarinic treatments in overactive bladder: A systematic review and meta-analysis
C Chapple et al.
EUROPEAN UROLOGY (2005)
Drugs with anticholinergic properties and cognitive performance in the elderly:: results from the PAQUID Study
N Lechevallier-Michel et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Stress and combined exposure to low doses of pyridostigmine bromide, deet, and permethrin produce neurochemical and neuropathological alterations in cerebral cortex, hippocampus, and cerebellum
A Abdel-Rahman et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2004)
Antimuscarinics for treatment of overactive bladder
KE Andersson
LANCET NEUROLOGY (2004)
M2 muscarinic acetylcholine receptor knock-out mice show deficits in behavioral flexibility, working memory, and hippocampal plasticity
T Seeger et al.
JOURNAL OF NEUROSCIENCE (2004)
Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs
EK Perry et al.
ANNALS OF NEUROLOGY (2003)
Selective cognitive dysfunction in acetylcholine M-1 muscarinic receptor mutant mice
SG Anagnostaras et al.
NATURE NEUROSCIENCE (2003)
Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging
JM Starr et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
Anticholinergic burden and the risk of falls among elderly psychiatric inpatients: A 4-year case-control study
D Aizenberg et al.
INTERNATIONAL PSYCHOGERIATRICS (2002)
Sensory-motor gating and cognitive control by the brainstem cholinergic system
Y Kobayashi et al.
NEURAL NETWORKS (2002)
Characterization of central inhibitory muscarinic autoreceptors by the use of muscarinic acetylcholine receptor knock-out mice
WL Zhang et al.
JOURNAL OF NEUROSCIENCE (2002)
Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice
DJ Gerber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system
A Todorova et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean
M Yamada et al.
NATURE (2001)
Urinary incontinence: Does it increase risk for falls and fractures?
JS Brown et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2000)
Share Paper
